Kayne Anderson Rudnick Investment Management LLC Acquires 38,912 Shares of Atrion Co. (NASDAQ:ATRI)

Kayne Anderson Rudnick Investment Management LLC raised its holdings in Atrion Co. (NASDAQ:ATRI) by 41.6% during the 1st quarter, Holdings Channel reports. The institutional investor owned 132,363 shares of the medical instruments supplier’s stock after acquiring an additional 38,912 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned about 0.07% of Atrion worth $116,305,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Quadrant Capital Group LLC acquired a new stake in Atrion in the 1st quarter valued at $27,000. O Shaughnessy Asset Management LLC acquired a new stake in Atrion in the 1st quarter valued at $100,000. PNC Financial Services Group Inc. acquired a new stake in Atrion in the 4th quarter valued at $130,000. Amundi Pioneer Asset Management Inc. acquired a new stake in Atrion in the 4th quarter valued at $148,000. Finally, Legal & General Group Plc increased its stake in Atrion by 7.8% in the 4th quarter. Legal & General Group Plc now owns 249 shares of the medical instruments supplier’s stock valued at $185,000 after buying an additional 18 shares during the last quarter. Hedge funds and other institutional investors own 59.94% of the company’s stock.

Separately, BidaskClub upgraded shares of Atrion from a “hold” rating to a “buy” rating in a research note on Thursday, May 30th.

In other news, Director Ronald Nicholas Spaulding sold 170 shares of the business’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $903.00, for a total transaction of $153,510.00. Following the transaction, the director now directly owns 2,158 shares in the company, valued at approximately $1,948,674. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 22.07% of the stock is owned by insiders.

Shares of Atrion stock traded up $3.22 during trading on Friday, hitting $878.02. 58,470 shares of the stock were exchanged, compared to its average volume of 7,062. The firm has a market capitalization of $1.63 billion, a PE ratio of 46.46 and a beta of 0.40. Atrion Co. has a 1-year low of $573.50 and a 1-year high of $948.03.

Atrion (NASDAQ:ATRI) last released its quarterly earnings data on Wednesday, May 8th. The medical instruments supplier reported $5.07 earnings per share for the quarter. The company had revenue of $41.61 million for the quarter. Atrion had a net margin of 22.76% and a return on equity of 16.89%.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be paid a dividend of $1.35 per share. The ex-dividend date is Thursday, June 13th. This represents a $5.40 annualized dividend and a dividend yield of 0.62%.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this report on another domain, it was illegally copied and reposted in violation of US & international copyright & trademark law. The correct version of this report can be accessed at https://www.com-unik.info/2019/06/16/kayne-anderson-rudnick-investment-management-llc-acquires-38912-shares-of-atrion-co-nasdaqatri.html.

About Atrion

Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.

Featured Story: What is a Reverse Stock Split?

Want to see what other hedge funds are holding ATRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Atrion Co. (NASDAQ:ATRI).

Institutional Ownership by Quarter for Atrion (NASDAQ:ATRI)

Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit